Vaccines are one of our greatest tools to protect against infectious diseases and the world waits with bated breath for a vaccine against coronavirus (COVID-19). The wait might be much shorter if we can hone new methods of ...
Mar 30, 2020
0
12
The Moderna COVID-19 vaccine, which the company says was recently demonstrated to have 94 percent efficacy, causes the human immune system to produce potent antibodies that endure for at least three months, a study showed ...
Dec 3, 2020
0
742
Researchers at the University of Iowa and the University of Georgia have developed a vaccine that fully protects mice against a lethal dose of MERS, a close cousin of the SARS-CoV2 coronavirus that causes COVID-19.
Apr 7, 2020
0
1631
A genetically edited form of a herpes simplex virus—rewired to keep it from taking refuge in the nervous system and eluding an immune response—has outperformed a leading vaccine candidate in a new study from the University ...
Nov 6, 2020
0
151
A new study presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) and published in The Lancet Rheumatology, shows that the antibody—but not the T-cell—response to the first ...
Jul 9, 2021
0
2
Effective vaccines, without a needle: Since the start of the COVID pandemic, researchers have doubled down on efforts to create patches that deliver life-saving drugs painlessly to the skin, a development that could revolutionize ...
Oct 29, 2021
0
184
New research to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal, (23-26 April), has shown that a longer interval between primary COVID-19 vaccine doses ...
Apr 22, 2022
0
45
Infectious disease scientists report early development of a potential universal vaccine for Ebola viruses that preclinical tests show might neutralize all four species of these deadly viruses infecting people in recent outbreaks, ...
Apr 16, 2020
0
1849
Scientists at Imperial College London say they are immunizing hundreds of people with an experimental coronavirus vaccine in an early trial after seeing no worrying safety problems in a small number vaccinated so far.
Jul 30, 2020
0
288
The US biotech firm Inovio reported preliminary but encouraging results Tuesday from tests of an experimental coronavirus vaccine.
Jun 30, 2020
0
249
